{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T18:13:26Z","timestamp":1776276806163,"version":"3.50.1"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Coronary artery bypass grafting (CABG) is a common treatment for coronary artery disease (CAD), but it poses significant perioperative risks, including thrombosis and bleeding, especially in elderly patients with comorbidities such as nephrotic syndrome and pulmonary infection. Thromboelastography (TEG) has emerged as a valuable tool for guiding dual antiplatelet therapy (DAPT) and optimizing drug treatment strategies in these complex cases. A case presentation of a 65-year-old male patient with nephrotic syndrome and pulmonary infection undergoing CABG surgery was reported. The patient's management included TEG-guided DAPT, routine monitoring of coagulation parameters, and adjustments based on clinical findings and laboratory results. TEG effectively guided DAPT and anticoagulant therapy, ensuring appropriate coagulation status and minimizing bleeding risks. The patient's postoperative management included dual antiplatelet therapy with aspirin and clopidogrel, adjusted based on TEG results. Additional interventions included the use of proton pump inhibitors to prevent gastrointestinal bleeding and tailored antibiotic therapy for pulmonary infection. The patient's clinical outcomes improved, with stable coagulation parameters and controlled infection. Clinical pharmacists play a critical role in optimizing medication regimens and ensuring patient safety through multidisciplinary collaboration. Future studies should further explore the integration of TEG and other advanced tools in personalized pharmaceutical care for complex post-CABG cases.<\/jats:p>","DOI":"10.3389\/fcvm.2025.1595027","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T05:27:27Z","timestamp":1761283647000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Antithrombotic management in an elderly CABG patient with nephrotic syndrome: a case report"],"prefix":"10.3389","volume":"12","author":[{"given":"Feng","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liu-Cheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao-Miao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Ping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai-Li","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"101059","DOI":"10.1016\/j.accpm.2022.101059","article-title":"Guidelines on enhanced recovery after cardiac surgery under cardiopulmonary bypass or off-pump","volume":"41","author":"Mertes","year":"2022","journal-title":"Anaesth Crit Care Pain Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1093\/ejcts\/ezz267","article-title":"2019 EACTS\/EACTA\/EBCP guidelines on cardiopulmonary bypass in adult cardiac surgery","volume":"57","author":"Wahba","year":"2020","journal-title":"Eur J Cardiothorac Surg"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1133662","DOI":"10.3389\/fcvm.2023.1133662","article-title":"Escitalopram-induced sinus bradycardia in coronary heart disease combined with depression: a case report and review of literature","volume":"10","author":"Li","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/ddr.22025","article-title":"Treatment strategies and pharmacist-led medication management for Helicobacter pylori infection","volume":"84","author":"Wang","year":"2023","journal-title":"Drug Dev Res"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1512784","DOI":"10.3389\/fcvm.2025.1512784","article-title":"Case report: practice of whole-course pharmaceutical care: a case in hypertrophic cardiomyopathy and a review of the pharmacist\u2019s role","volume":"12","author":"Li","year":"2025","journal-title":"Front Cardiovasc Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e020413","DOI":"10.1161\/JAHA.120.020413","article-title":"Dual antiplatelet therapy with clopidogrel and aspirin versus aspirin monotherapy in patients undergoing coronary artery bypass graft surgery","volume":"10","author":"Qu","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"B7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jacc.2021.09.005","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: executive summary: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"79","author":"Lawton","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.jacc.2010.10.029","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (platelet inhibition and patient outcomes) trial","volume":"57","author":"Held","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.21037\/jtd-20-3407","article-title":"Aspirin plus ticagrelor or clopidogrel on graft patency one year after coronary bypass grafting: a single-center, randomized, controlled trial","volume":"13","author":"Tang","year":"2021","journal-title":"J Thorac Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1161\/CIR.0000000000001168","article-title":"2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American heart association\/American college of cardiology joint committee on clinical practice guidelines","volume":"148","author":"Virani","year":"2023","journal-title":"Circulation"},{"key":"B11","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.21037\/jtd.2016.12.77","article-title":"The application of thromboelastogram in detection of indexes of antiplatelet therapy for coronary heart disease","volume":"8","author":"Zhao","year":"2016","journal-title":"J Thorac Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/1053-0770(94)90052-3","article-title":"Evaluation of coagulation during cardiopulmonary bypass with a heparinase-modified thromboelastographic assay","volume":"8","author":"Tuman","year":"1994","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e207","DOI":"10.1016\/j.chest.2022.07.025","article-title":"Perioperative management of antithrombotic therapy: an American college of chest physicians clinical practice guideline","volume":"162","author":"Douketis","year":"2022","journal-title":"Chest"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1093\/eurheartj\/eht042","article-title":"Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy","volume":"34","author":"Agewall","year":"2013","journal-title":"Eur Heart J"},{"key":"B15","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1161\/CIR.0000000000000182","article-title":"Secondary prevention after coronary artery bypass graft surgery: a scientific statement from the American heart association","volume":"131","author":"Kulik","year":"2015","journal-title":"Circulation"},{"key":"B16","doi-asserted-by":"publisher","first-page":"102162","DOI":"10.1016\/j.rpth.2023.102162","article-title":"Thromboembolism in nephrotic syndrome: controversies and uncertainties","volume":"7","author":"Parker","year":"2023","journal-title":"Res Pract Thromb Haemostasis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1111\/jocs.15283","article-title":"Anticoagulation and antiplatelet therapy post coronary artery bypass surgery","volume":"36","author":"Sembi","year":"2021","journal-title":"J Card Surg"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s11845-022-03129-0","article-title":"Adherence to secondary prevention recommendations after coronary artery bypass graft surgery","volume":"192","author":"Keating","year":"2023","journal-title":"Ir J Med Sci"},{"key":"B19","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1177\/1074248420987445","article-title":"Secondary prevention medications post coronary artery bypass grafting surgery-A literature review","volume":"26","author":"Dimitriadis","year":"2021","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"B20","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jacc.2018.10.049","article-title":"Antithrombotic therapy following CABG: for the patient, not the bypass graft","volume":"73","author":"Alexander","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1161\/CIRCOUTCOMES.113.000770","article-title":"Center-level variation in infection rates after coronary artery bypass grafting","volume":"7","author":"Shih","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"B22","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/0003-4975(91)90787-Q","article-title":"Risk factors for nosocomial pneumonia after coronary artery bypass graft operations","volume":"51","author":"Gaynes","year":"1991","journal-title":"Ann Thorac Surg"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.athoracsur.2016.03.074","article-title":"A preoperative risk model for postoperative pneumonia after coronary artery bypass grafting","volume":"102","author":"Strobel","year":"2016","journal-title":"Ann Thorac Surg"},{"key":"B24","doi-asserted-by":"publisher","first-page":"70","DOI":"10.21470\/1678-9741-2017-0209","article-title":"Risk factors and outcome of acute kidney injury after isolated CABG surgery: a prospective cohort study","volume":"34","author":"Amini","year":"2019","journal-title":"Braz J Cardiovasc Surg"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.2147\/JIR.S425485","article-title":"Analysis of risk factors and intervention strategies for acute kidney injury after cardiac valve replacement","volume":"16","author":"Jiang","year":"2023","journal-title":"J Inflamm Res"},{"key":"B26","first-page":"23","article-title":"Thromboelastography platelet mapping\u2014a useful preoperative tool to reduce transfusion requirement by determining timing of coronary artery bypass graft surgery in patients taking dual antiplatelet medication: a pilot study from Eastern India","volume":"5","author":"Datta","year":"2021","journal-title":"J Card Crit Care"},{"key":"B27","first-page":"108","article-title":"Use of thromboelastography platelet mapping for assessment of individual platelet response secondary to oral antiplatelet therapy after percutaneous coronary intervention: an attempt to start personalized antiplatelet therapy in India","volume":"5","author":"Datta","year":"2021","journal-title":"J Card Crit Care"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1595027\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T05:27:28Z","timestamp":1761283648000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1595027\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":27,"alternative-id":["10.3389\/fcvm.2025.1595027"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2025.1595027","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"article-number":"1595027"}}